127 related articles for article (PubMed ID: 33501869)
1. The Expression and Role of microRNA-133a in Plasma of Patients with Kawasaki Disease.
Luo Y; Yu M; Li P; Huang L; Wu J; Kong M; Li Y; Wu Z; Kang Z; Yi L; Yang Z
Immunol Invest; 2022 May; 51(4):826-838. PubMed ID: 33501869
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of miR-184 and miR-19a-3p induces endothelial dysfunction by targeting AGO2 in Kawasaki disease.
Liao J; Guo X; Fan X; Zhang X; Xu M
Cardiol Young; 2023 Oct; 33(10):1962-1966. PubMed ID: 36424716
[TBL] [Abstract][Full Text] [Related]
3. miR-483 Targeting of CTGF Suppresses Endothelial-to-Mesenchymal Transition: Therapeutic Implications in Kawasaki Disease.
He M; Chen Z; Martin M; Zhang J; Sangwung P; Woo B; Tremoulet AH; Shimizu C; Jain MK; Burns JC; Shyy JY
Circ Res; 2017 Jan; 120(2):354-365. PubMed ID: 27923814
[TBL] [Abstract][Full Text] [Related]
4. A plasma mir-125a-5p as a novel biomarker for Kawasaki disease and induces apoptosis in HUVECs.
Li Z; Jiang J; Tian L; Li X; Chen J; Li S; Li C; Yang Z
PLoS One; 2017; 12(5):e0175407. PubMed ID: 28467514
[TBL] [Abstract][Full Text] [Related]
5. Non-coding RNAs in Kawasaki disease: Molecular mechanisms and clinical implications.
Yang F; Ao X; Ding L; Ye L; Zhang X; Yang L; Zhao Z; Wang J
Bioessays; 2022 Jun; 44(6):e2100256. PubMed ID: 35355301
[TBL] [Abstract][Full Text] [Related]
6. Post-transcriptional modulation of protein phosphatase PPP2CA and tumor suppressor PTEN by endogenous siRNA cleaved from hairpin within PTEN mRNA 3'UTR in human liver cells.
Gao YE; Wang Y; Chen FQ; Feng JY; Yang G; Feng GX; Yang Z; Ye LH; Zhang XD
Acta Pharmacol Sin; 2016 Jul; 37(7):898-907. PubMed ID: 27133296
[TBL] [Abstract][Full Text] [Related]
7. Expression levels of plasma miRNA-21 and NT-proBNP in children with Kawasaki disease and their clinical significance.
Zhang R; Wu L; Zhang HJ; Gao XJ; Pan XT; Wang XR; Ye H; Liu GH
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12757-12762. PubMed ID: 33378024
[TBL] [Abstract][Full Text] [Related]
8. miRNA-133a-5p Inhibits the Expression of Osteoblast Differentiation-Associated Markers by Targeting the 3' UTR of RUNX2.
Zhang W; Wu Y; Shiozaki Y; Sugimoto Y; Takigawa T; Tanaka M; Matsukawa A; Ozaki T
DNA Cell Biol; 2018 Mar; 37(3):199-209. PubMed ID: 29359964
[TBL] [Abstract][Full Text] [Related]
9. CircRNA7632 down-regulation alleviates endothelial cell dysfunction in Kawasaki disease via regulating IL-33 expression.
Qiu H; Ni C; Jia C; Rong X; Chu M; Wu R; Han B
Cell Stress Chaperones; 2023 Jul; 28(4):363-374. PubMed ID: 37166618
[TBL] [Abstract][Full Text] [Related]
10. miR‑186, a serum microRNA, induces endothelial cell apoptosis by targeting SMAD6 in Kawasaki disease.
Wu R; Shen D; Sohun H; Ge D; Chen X; Wang X; Chen R; Wu Y; Zeng J; Rong X; Su X; Chu M
Int J Mol Med; 2018 Apr; 41(4):1899-1908. PubMed ID: 29344637
[TBL] [Abstract][Full Text] [Related]
11. miR-133a regulates vitamin K 2,3-epoxide reductase complex subunit 1 (VKORC1), a key protein in the vitamin K cycle.
Pérez-Andreu V; Teruel R; Corral J; Roldán V; García-Barberá N; Salloum-Asfar S; Gómez-Lechón MJ; Bourgeois S; Deloukas P; Wadelius M; Vicente V; González-Conejero R; Martínez C
Mol Med; 2013 Jan; 18(1):1466-72. PubMed ID: 23154637
[TBL] [Abstract][Full Text] [Related]
12. miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma.
Kano M; Seki N; Kikkawa N; Fujimura L; Hoshino I; Akutsu Y; Chiyomaru T; Enokida H; Nakagawa M; Matsubara H
Int J Cancer; 2010 Dec; 127(12):2804-14. PubMed ID: 21351259
[TBL] [Abstract][Full Text] [Related]
13. Serum miR-92a-3p as a New Potential Biomarker for Diagnosis of Kawasaki Disease with Coronary Artery Lesions.
Rong X; Jia L; Hong L; Pan L; Xue X; Zhang C; Lu J; Jin Z; Qiu H; Wu R; Chu M
J Cardiovasc Transl Res; 2017 Feb; 10(1):1-8. PubMed ID: 27981487
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of miRNA-122 in Kawasaki disease.
Lv HF; Sun XQ; Zhou HX; Qin Z; Shi YY; Wang Q; Li F
Eur Rev Med Pharmacol Sci; 2020 Nov; 24(21):11222-11226. PubMed ID: 33215440
[TBL] [Abstract][Full Text] [Related]
15. Bone Marrow-Derived MicroRNA-223 Works as an Endocrine Genetic Signal in Vascular Endothelial Cells and Participates in Vascular Injury From Kawasaki Disease.
Chu M; Wu R; Qin S; Hua W; Shan Z; Rong X; Zeng J; Hong L; Sun Y; Liu Y; Li W; Wang S; Zhang C
J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28196816
[TBL] [Abstract][Full Text] [Related]
16. A useful method of identifying of miRNAs which can down-regulate Zeb-2.
Oba S; Mizutani T; Suzuki E; Nishimatsu H; Takahashi M; Ogawa Y; Kimura K; Hirata Y; Fujita T
BMC Res Notes; 2013 Nov; 6():470. PubMed ID: 24245745
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-15a, microRNA-15b and microRNA-16 inhibit the human dopamine D1 receptor expression in four cell lines by targeting 3'UTR -12 bp to + 154 bp.
Wu X; Xu FL; Xia X; Wang BJ; Yao J
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):276-287. PubMed ID: 31858826
[No Abstract] [Full Text] [Related]
18. Identification of differentially expressed microRNAs in acute Kawasaki disease.
Chen Y; Ding YY; Ren Y; Cao L; Xu QQ; Sun L; Xu MG; Lv HT
Mol Med Rep; 2018 Jan; 17(1):932-938. PubMed ID: 29115644
[TBL] [Abstract][Full Text] [Related]
19. Elevated serum level of microRNA (miRNA)-200c and miRNA-371-5p in children with Kawasaki disease.
Yun KW; Lee JY; Yun SW; Lim IS; Choi ES
Pediatr Cardiol; 2014 Jun; 35(5):745-52. PubMed ID: 24259014
[TBL] [Abstract][Full Text] [Related]
20. Complex interaction between dengue virus replication and expression of miRNA-133a.
Castillo JA; Castrillón JC; Diosa-Toro M; Betancur JG; St Laurent G; Smit JM; Urcuqui-Inchima S
BMC Infect Dis; 2016 Jan; 16():29. PubMed ID: 26818704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
